A Tumor-Homing Peptide Platform Enhances Drug Solubility, Improves Blood–Brain Barrier Permeability and Targets Glioblastoma

Background: Glioblastoma (GBM) is the most common and deadliest malignant primary brain tumor, contributing significant morbidity and mortality among patients. As current standard-of-care demonstrates limited success, the development of new efficacious GBM therapeutics is urgently needed. Major chal...

Full description

Bibliographic Details
Main Authors: Cho, Choi-Fong, Farquhar, Charlotte E., Fadzen, Colin M., Scott, Benjamin, Zhuang, Pei, von Spreckelsen, Niklas, Loas, Andrei, Hartrampf, Nina, Pentelute, Bradley L., Lawler, Sean E.
Other Authors: Massachusetts Institute of Technology. Department of Chemistry
Format: Article
Published: Multidisciplinary Digital Publishing Institute 2022
Online Access:https://hdl.handle.net/1721.1/142518